Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Synthesis biological evaluation and molecular docking of isatin hybrids as anti-cancer and anti-microbial agentsAltamimi, Mohammad ; Syed, Saeed Ali ; Tuzun, Burak ; Alhazani, Mohammad Rashid ; Alnemer, Osamah ; Bari, AhmedJournal of enzyme inhibition and medicinal chemistry, 2024-12, Vol.39 (1), p.2288548-2288548 [Periódico revisado por pares]England: Taylor & Francis GroupTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Acetazolamide and human carbonic anhydrases: retrospect, review and discussion of an intimate relationshipTsikas, DimitriosJournal of enzyme inhibition and medicinal chemistry, 2024-12, Vol.39 (1), p.2291336-2291336 [Periódico revisado por pares]England: Taylor & Francis GroupTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Ligand-based pharmacophore modelling, structure optimisation, and biological evaluation for the identification of 2-heteroarylthio- N -arylacetamides as novel HSP90 C-terminal inhibitorsLiu, Yajun ; Li, Chenyao ; Li, Yajing ; Zhang, Shuming ; Zhang, Ning ; Bian, Xiaobo ; Tan, ShutaoJournal of enzyme inhibition and medicinal chemistry, 2024-12, Vol.39 (1), p.2290912-2290912 [Periódico revisado por pares]England: Taylor & Francis GroupTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Design, synthesis and biological evaluation of novel podophyllotoxin derivatives as tubulin-targeting anticancer agentsGuo, Yujin ; Chen, Beibei ; Guo, Jinxiu ; Jiang, Pei ; Wang, Jianhua ; Sun, WenxuePharmaceutical biology, 2024-12, Vol.62 (1), p.233-249 [Periódico revisado por pares]England: Taylor & FrancisTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Evaluation of N -alkyl isatins and indoles as acetylcholinesterase and butyrylcholinesterase inhibitorsAlcorn, Kaitlyn N ; Oberhauser, Isabelle A ; Politeski, Matthew D ; Eckroat, Todd JJournal of enzyme inhibition and medicinal chemistry, 2024-12, Vol.39 (1), p.2286935-2286935 [Periódico revisado por pares]England: Taylor & Francis GroupTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Application of high intensity focused ultrasound combined with nanomaterials in anti-tumor therapyZhang, Xuehui ; He, Ningning ; Zhang, Liang ; Dai, Tong ; Sun, Zihan ; Shi, Yuqing ; Li, Shangyong ; Yu, NingDrug delivery, 2024-12, Vol.31 (1), p.2342844-2342844 [Periódico revisado por pares]England: Taylor & Francis GroupTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Design, synthesis, molecular modelling and biological evaluation of novel 6-amino-5-cyano-2-thiopyrimidine derivatives as potent anticancer agents against leukemia and apoptotic inducersAhmed, Naglaa M ; Mohamed, Mosaad S ; Awad, Samir M ; Abd El-Hameed, Rania H ; El-Tawab, Neama A Abd ; Gaballah, Mohamed S ; Said, Ahmed MJournal of enzyme inhibition and medicinal chemistry, 2024-12, Vol.39 (1), p.2304625-2304625 [Periódico revisado por pares]England: Taylor & FrancisTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Development of certain benzylidene coumarin derivatives as anti-prostate cancer agents targeting EGFR and PI3Kβ kinasesElagawany, Mohamed ; Abdel Ghany, Lina M A ; Ibrahim, Tarek S ; Alharbi, Abdulrhman S ; Abdel-Aziz, Mohamed S ; El-Labbad, Eman M ; Ryad, NohaJournal of enzyme inhibition and medicinal chemistry, 2024-12, Vol.39 (1), p.2311157-2311157 [Periódico revisado por pares]England: Taylor & FrancisTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Advances in cell membrane-based biomimetic nanodelivery systems for natural productsZhang, Yifeng ; Zhang, Qian ; Li, Chunhong ; Zhou, Ziyun ; Lei, Hui ; Liu, Minghua ; Zhang, DanDrug delivery, 2024-12, Vol.31 (1), p.2361169-2361169 [Periódico revisado por pares]England: Taylor & FrancisTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Glutaminase inhibition as potential cancer therapeutics: current status and future applicationsCyriac, Rajath ; Lee, KwanghoJournal of enzyme inhibition and medicinal chemistry, 2024-12, Vol.39 (1), p.2290911-2290911 [Periódico revisado por pares]England: Taylor & Francis GroupTexto completo disponível |